Girdhar Pharmaceuticals Private Limited
About Girdhar Pharmaceuticals Private Limited
Data last updated:
Girdhar Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 12 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC170324.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Mukesh Kumar Agarwal and Suman Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 59 Ashirwad Appartments Patpar Ganj Ip Extension, New Delhi, Delhi, India – 110093.
As per the financials filed for FY 2025, the company reported a revenue of ₹30,000. For the same year it recorded a net profit of ₹3,440 (net margin 11.5%) and EBITDA of ₹4,600 (EBITDA margin 15.3%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 36% over five years.
As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹20 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4.99 Cr; the latest was in March 2018.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Girdhar Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address59 Ashirwad Appartments Patpar Ganj Ip Extension, New Delhi, Delhi, India – 110093
- IndustryHealthcare, Hospitals
To see the full contact details of Girdhar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Girdhar Pharmaceuticals Private Limited
FY 2025 filings availableGirdhar Pharmaceuticals Private Limited reported revenue of ₹30,000 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,600 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,440 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.3% | ||||
| Net Profit Margin | 11.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Girdhar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Girdhar Pharmaceuticals Private Limited
Girdhar Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Agarwal | Director | 19 Jan 2013 | 13 Years 9 Months | Current |
| Suman Agarwal Also directs: DRMS and Associate LLP, Divri Health and Education LLP, Chandra Laxmi Hospital Private Limited and 1 more | Director | 01 Feb 2018 | 8 Years 8 Months | Current |
Auditor
Girdhar Pharmaceuticals Private Limited is audited by Rama k Gupta & Company Chartered Accountants for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rama k Gupta & Company Chartered Accountants | FY 2023 | 005005C |
Shareholding
The shareholding of Girdhar Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Girdhar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2025 | 101087472 | Idbi Bank Limited | ₹4 Cr | Open | |
| 20 Jan 2024 | 100893117 | Hdfc Bank Limited | ₹20 Cr | Satisfied |
To see the full charge records of Girdhar Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Girdhar Pharmaceuticals Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4.99 Cr; the latest was in March 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2014 | Funding round | ₹4.99 Cr | Investors: VKM Industries, Sai Yash Rama Infrastructure, 2 individuals |
| Aug 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Girdhar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Girdhar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Girdhar Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Girdhar Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Raghubar Dayal Gupta ceased to be Director on 07 Mar 2018.
Frequently asked questions
Girdhar Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in hospitals, within the healthcare industry. It was incorporated on 12 November 2007 (19+ years old) and is registered under CIN U24233DL2007PTC170324.
Girdhar Pharmaceuticals has 2 current directors:
- Mukesh Kumar Agarwal - Director
- Suman Agarwal - Director
The latest financial statements of Girdhar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Girdhar Pharmaceuticals is U24233DL2007PTC170324. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Girdhar Pharmaceuticals was incorporated on 12 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Girdhar Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4.99 Cr; the latest was in March 2018.
Raghubar Dayal Gupta ceased to be Director on 07 Mar 2018. Suman Agarwal was appointed as Director on 01 Feb 2018. Aman Mittal ceased to be Director on 20 Jan 2013. Girdhar Pharmaceuticals has 5 board changes on record in total.
The registered office of Girdhar Pharmaceuticals is at 59 Ashirwad Appartments Patpar Ganj Ip Extension, New Delhi, Delhi, India – 110093.
Girdhar Pharmaceuticals operates in the healthcare industry, in the hospitals segment.
Girdhar Pharmaceuticals has open charges of ₹4 Cr and satisfied charges of ₹20 Cr as per latest MCA filings.